GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Average Recommendation of “Hold” by Analysts

GE HealthCare Technologies Inc. (NASDAQ:GEHC) has been assigned an average rating of “Hold” from the fourteen research firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $92.1667.

A number of research analysts recently issued reports on GEHC shares. Jefferies Financial Group boosted their target price on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Thursday, December 11th. Bank of America lifted their price objective on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research note on Monday, January 5th. Piper Sandler boosted their price objective on GE HealthCare Technologies from $91.00 to $94.00 and gave the company an “overweight” rating in a report on Friday, January 30th. Evercore upped their target price on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. Finally, UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and raised their target price for the stock from $73.00 to $77.00 in a report on Thursday, January 15th.

Hedge Funds Weigh In On GE HealthCare Technologies

Several institutional investors have recently made changes to their positions in GEHC. Auto Owners Insurance Co lifted its stake in shares of GE HealthCare Technologies by 9,525.4% in the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after purchasing an additional 33,629,559 shares during the period. Norges Bank acquired a new stake in GE HealthCare Technologies during the fourth quarter valued at $596,024,000. Dodge & Cox increased its holdings in GE HealthCare Technologies by 42.1% in the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after buying an additional 6,982,441 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC purchased a new position in GE HealthCare Technologies in the fourth quarter valued at $533,655,000. Finally, Capital Research Global Investors raised its position in shares of GE HealthCare Technologies by 25.0% in the third quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock worth $1,875,400,000 after acquiring an additional 4,998,154 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Performance

GEHC opened at $69.23 on Friday. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. GE HealthCare Technologies has a 12-month low of $57.65 and a 12-month high of $89.77. The firm has a 50 day moving average of $77.91 and a two-hundred day moving average of $78.26. The firm has a market capitalization of $31.59 billion, a PE ratio of 15.18, a P/E/G ratio of 1.52 and a beta of 1.03.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $1.40 by $0.04. The business had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period in the prior year, the firm earned $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, analysts anticipate that GE HealthCare Technologies will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio is currently 3.07%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.